Cost-effectiveness of a mailed educational reminder to increase colorectal cancer screening

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Lee, Jeffrey K ^a   Groessl, Erik J ^a,b,c   Ganiats, Theodore G ^a,c   Ho, Samuel B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c University of California ^*  (United States)

Author keywords

Colorectal Cancer; Cost effectiveness; FOBT; Reminder; Screening

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH EDUCATION; HUMAN; INCREMENTAL COST EFFECTIVENESS RATIO; LABOR; LABORATORY APPARATUS, EQUIPMENT AND SUPPLIES; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OCCULT BLOOD TEST; OUTCOME ASSESSMENT; POSTAL MAIL; REMINDER SYSTEM; SENSITIVITY ANALYSIS; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DOUBLE BLIND PROCEDURE; ECONOMICS; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; OCCULT BLOOD; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; VETERAN;

COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; FEMALE; HEALTH EDUCATION; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; REMINDER SYSTEMS; UNITED STATES; VETERANS;

EID: 80052021383     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-93     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun TJ. Cancer statistics 2008. CA Cancer J Clin 2008, 58:71-96. 10.3322/CA.2007.0010, 18287387.
2. Centers for Disease Control and Prevention (CDC) Use of colorectal cancer tests - United States., 2002, 2004, and 2006. Morb Mortal Wkly Rep 2008, 57:253-58. Centers for Disease Control and Prevention (CDC).
3. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1477. 10.1016/S0140-6736(96)03386-7, 8942775.
4. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348:1467-1471. 10.1016/S0140-6736(96)03430-7, 8942774.
5. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality form colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993, 328:1365-1371. 10.1056/NEJM199305133281901, 8474513.
6. Screening for colorectal cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008, 149:627-637.
7. National Comprehensive Cancer Network (NCCN) Colorectal cancer screening. Clinical Practice Guidelines in Oncology -- v.1.2009 2009, Jenkintown, PA: NCCN, Accessed April 4, 2009, National Comprehensive Cancer Network (NCCN)., http://www.nccn.org/professionals/physician_gls/PDF/colorectal_screening.pdf
8. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997, 89:1406-1422. 10.1093/jnci/89.19.1406, 9326910.
9. Winchester DP, Shull JH, Scanlon EF, Murrell JV, Smeltzer C, Vrba P, Iden M, Streelman DH, Magpayo R, Dow JW, Synlvester J. A mass screening program for colorectal cancer using chemical testing for occult blood in the stool. Cancer 1980, 45:2955-2958. 10.1002/1097-0142(19800615)45:12<2955::AID-CNCR2820451211>3.0.CO;2-T, 7388738.
10. Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med 2005, 20:278-282. 10.1111/j.1525-1497.2005.40023.x, 1490069, 15836533.
11. Mahon SM. The impact of mailing fecal occult blood test kits on return rate in a community cancer screening center. Oncol Nurs Forum 1995, 22:1269-1273.
12. Lee JK, Reis V, Liu S, Conn L, Groessl EJ, Ganiats TG, Ho SB. Improving fecal occult blood testing compliance using a mailed educational reminder. J Gen Intern Med 2009, 24:1192-1197. 10.1007/s11606-009-1087-5, 2771232, 19774423.
13. Lantz PM, Stencil D, Lippert MT, Jaros L, Eaker ED. Implementation issues and costs associated with a proven strategy for increasing breast and cervical cancer screening among low income women. J Public Health Manag Pract 1996, 2:54-59.
14. Saywell RM, Champion VL, Skinner CS, Menon U, Daggy J. A cost-effectiveness comparison of three tailored interventions to increase mammography screening. J Womens Health 2004, 13:909-918.
15. Denberg TD, Coombes JM, Byers TE, Marcus AC, Feinberg LE, Steiner JF, Ahnen DJ. Effect of a mailed brochure on appointment-keeping for screening colonoscopy: a randomized trial. Ann Intern Med 2006, 145:895-900.
16. Chirikos TN, Christman LK, Hunter S, Roetzheim RG. Cost-effectiveness of an intervention to increase cancer screening in primary care settings. Prev Med 2004, 39:230-238. 10.1016/j.ypmed.2004.03.021, 15226030.
17. Lewis CL, Brenner AT, Griffith JM, Pignone MP. The uptake and effect of a mailed multi-modal colon cancer screening intervention: A pilot controlled trial. Implement Sci 2008, 3:32. 10.1186/1748-5908-3-32, 2427049, 18518990.
18. Lairson DR, DiCarlo M, Myers RE, Wolf T, Cocroft J, Sifri R, Rosenthal M, Vernon SW, Wender R. Cost-effectiveness of targeted and tailored interventions on colorectal cancer screening use. Cancer 2008, 112:779-788. 10.1002/cncr.23232, 18098272.
19. Wolf MS, Fitzner KA, Powell EF, McCaffrey KR, Pickard AS, McKoy JM, Lindenberg J, Schumock GT, Carson KR, Ferreira MR, Dolan NC, Bennett CL. Costs and cost-effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among veterans. J Clin Oncol 2005, 23:8877-8883. 10.1200/JCO.2005.02.6278, 16314648.
20. Sequist TD, Franz C, Ayanian JZ. Cost-effectiveness of patient mailings to promote colorectal cancer screening. Med Care 2010, 48:553-557. 10.1097/MLR.0b013e3181dbd8eb, 20473196.
21. The Flesch Reading Ease Readability Formula. Accessed May 10, 2007., http://www.readabilityformulas.com
22. Latimer EA, Becker ER. Incorporating practice costs into the Resource-Based Relative Value Scale. Med Care 1992, 30:NS50-60. 10.1097/00005650-199211001-00005, 1434967.
23. American Medical Association. Socioeconomic Characteristics of Medical Practice 1991, Chicago: American Medical Association.
24. Physician Payment Review Commission. Practice Expenses Under the Medicare fee Schedule. A Resource-Based Approach 1992, Washington, DC: Physician Payment Review Commission.
25. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE, . Diabetes Prevention Research Group The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2005, 142:323-332. 2701392, 15738451, Diabetes Prevention Research Group.
26. Gold MR. Cost-Effectiveness in Health and Medicine. 1996, Oxford University Press Oxford, 1.
27. Shankaran V, McKoy JM, Dandade N, Nonzee N, Tigue CA, Bennett CL, Denberg TD. Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening. J Clin Oncol 2007, 25:5248-5253. 10.1200/JCO.2007.13.4098, 18024871.
28. Thompson RS, Michnich ME, Gray J, Friedlander L, Gilson B. Maximizing compliance with hemoccult screening for colon cancer in clinical practice. Med Care 1986, 24:904-914. 10.1097/00005650-198610000-00004, 3762240.
29. Myers RE, Ross EA, Wolf TA, Balshem A, Jepson C, Millner L. Behavioral interventions to increase adherence in colorectal cancer screening. Med Care 1991, 29:1039-1050. 10.1097/00005650-199110000-00009, 1921523.
30. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomized trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003, 10:117-22. 10.1258/096914103769011003, 14561262.
31. Ko CW, Dominitz JA, Nguyen TD. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests. Am J Med 2003, 115:111-114.
32. Levi Z, Rozen P, Hazari R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Leshno M, Niv Y. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007, 146:244-255.